Compare PLX & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLX | PDEX |
|---|---|---|
| Founded | 1993 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.5M | 189.2M |
| IPO Year | 1996 | 1995 |
| Metric | PLX | PDEX |
|---|---|---|
| Price | $2.00 | $64.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | ★ $56.00 |
| AVG Volume (30 Days) | ★ 771.4K | 23.6K |
| Earning Date | 05-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 345.00 |
| EPS | 0.22 | ★ 3.27 |
| Revenue | $52,744,000.00 | ★ $66,593,000.00 |
| Revenue This Year | $36.81 | $7.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $8.91 | $19.88 |
| Revenue Growth | N/A | ★ 23.68 |
| 52 Week Low | $1.34 | $23.52 |
| 52 Week High | $3.19 | $68.99 |
| Indicator | PLX | PDEX |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 59.45 |
| Support Level | $1.87 | $37.43 |
| Resistance Level | $2.17 | $68.99 |
| Average True Range (ATR) | 0.07 | 3.08 |
| MACD | 0.00 | -0.35 |
| Stochastic Oscillator | 35.09 | 50.88 |
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.